Back to discover
Drug

Electrolytes

In clinical development
Emerging researchLate-stage development

Also known as Electrolyte.

1
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Electrolytes
Aliases & brands
Electrolyte
RxNorm CUI
3793

Clinical trials

1 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
1
registered trials across all phases
LATEST COMPLETION 2022
1
Late-stage (III+)
1
Completed
PHASE DISTRIBUTIONn = 1
Phase 41

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Recent completions

Trials that read out recently, adding to the completed evidence base.

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Most influential
Recent papers
Major research themes2
Electric Capacitance1Wearable Electronic Devices1
Journals, researchers & institutions
Top journals
  • Chemical Society reviews1
Leading researchers
  • Chodankar NR1
  • Dubal DP1
  • Gomez-Romero P1
  • Kim DH1
Leading institutions
free-text, unnormalised
  • Catalan Institute of Nanoscience and Nanotechnology (ICN2)1
  • School of Chemical Engineering1
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials